The company's bacTRAP® technology identifies proteins produced by specific cell types in vivo without isolating those cells, making it particularly effective in the brain where many cell types are intermingled. Envoy's mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments, and their platform brings a new day in drug discovery by allowing for therapeutically modulating the activity of specific cell types.